Acute hepatitis E virus (HEV) infection is typically self-limiting and has a favourable prognosis. However, certain populations such as patients with pre-existing chronic liver disease may experience severe manifestations, including progression to acute-on-chronic liver failure (ACLF). Among viral hepatitis types, hepatitis A, E, and B are major causes of ACLF. Active screening and early diagnosis of HEV infection in patients with cirrhosis, especially those who develop ACLF, can improve management and enable timely antiviral therapy. Preventive measures, including HEV vaccination for high-risk groups, could reduce the morbidity and mortality associated with hepatitis E.
Citations
Citations to this article as recorded by
Virus de la hepatitis E: un problema de salud pública emergente María Teresa Pérez-Gracia, Lara Martínez-Celdrán, Clara Más-Comes Medicina Clínica.2026; 166(2): 107286. CrossRef
Efficacy and safety of mesenchymal stem cell therapy in acute on chronic liver failure: a systematic review and meta-analysis of randomized controlled clinical trials Wenming Lu, Longxiang Yan, Lulu Peng, Xuesong Wang, Xingkun Tang, Jing Du, Jing Lin, Zhengwei Zou, Lincai Li, Junsong Ye, Lin Zhou Stem Cell Research & Therapy.2025;[Epub] CrossRef
Hepatitis A and E Viruses Are Important Agents of Acute Severe Hepatitis in Asia: A Narrative Review Reina Sasaki-Tanaka, Tatsuo Kanda, Takeshi Yokoo, Hiroyuki Abe, Kazunao Hayashi, Akira Sakamaki, Hiroteru Kamimura, Shuji Terai Pathogens.2025; 14(5): 454. CrossRef
The role of bacterial outer membrane vesicles in inflammatory response of acute-on-chronic liver failure Xiaojing Qin, Shuang Wang, Zhanyao Yan, Ninghui Zhao, Jia Yao Frontiers in Microbiology.2025;[Epub] CrossRef
Ribavirina como tratamiento de hepatitis E aguda grave sobre hepatopatía crónica: experiencia clínica Alba Rabadán Mata, María Dolores Antón Conejero, José María Paredes Arquiola Medicina Clínica.2025; 165(6): 107187. CrossRef
Ribavirin as a treatment for severe acute hepatitis E on chronic liver disease: Clinical experience Alba Rabadán Mata, María Dolores Antón Conejero, José María Paredes Arquiola Medicina Clínica (English Edition).2025; 165(6): 107187. CrossRef
Reply to correspondence on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK” Yang-Hyun Baek Clinical and Molecular Hepatology.2025; 31(1): e123. CrossRef
Correspondence to editorial on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK” Kwanjoo Lee, Jaeyu Park, Jinseok Lee, Hayeon Lee, Yeonjung Ha, Dong Keon Yon Clinical and Molecular Hepatology.2025; 31(1): e87. CrossRef
Background/Aims Studies of hepatic steatosis (HS) effect on COVID-19 vaccine immunogenicity are lacking. We aimed to compare immunogenicity of BNT162b2 and CoronaVac among moderate/severe HS and control subjects.
Methods Two hundred ninety-five subjects who received BNT162b2 or CoronaVac vaccines from five vaccination centers were categorized into moderate/severe HS (controlled attenuation parameter ≥268 dB/m on transient elastography) (n=74) or control (n=221) groups. Primary outcomes were seroconversion rates of neutralising antibody by live virus Microneutralization (vMN) assay (titer ≥10) at day21 (BNT162b2) or day28 (CoronaVac) and day56 (both). Secondary outcome was highest-tier titer response (top 25% of vMN titer; cutoff: 160 [BNT162b2] and 20 [CoronaVac]) at day 56.
Results For BNT162b2 (n=228, 77.3%), there was no statistical differences in seroconversion rates (day21: 71.7% vs. 76.6%; day56: 100% vs. 100%) or vMN geometric mean titer (GMT) (day21: 13.2 vs. 13.3; day56: 91.9 vs. 101.4) among moderate/severe HS and control groups respectively. However, lower proportion of moderate/severe HS patients had highest-tier response (day56: 5.0% vs. 15.5%; P=0.037). For CoronaVac (n=67, 22.7%), there was no statistical differences in seroconversion rates (day21: 7.1% vs. 15.1%; day56: 64.3% vs. 83.0%) or vMN GMT (5.3 vs. 5.8,) at day28. However, moderate/severe HS patients had lower vMN GMT (9.1 vs. 14.8, P=0.021) at day 56 with lower proportion having highest-tier response (21.4% vs. 52.8%, P=0.036).
Conclusions While there was no difference in seroconversion rate between moderate/severe HS and control groups after two doses of vaccine, a lower proportion of moderate/severe HS patients achieved highest-tier response for either BNT162b2 or CoronaVac.
Citations
Citations to this article as recorded by
Gut microbiota is associated with persistence of longer-term BNT162b2 vaccine immunogenicity Ho Yu Ng, Yunshi Liao, Ching Lung Cheung, Ruiqi Zhang, Kwok Hung Chan, Wai-Kay Seto, Wai K. Leung, Ivan F. N. Hung, Tommy T. Y. Lam, Ka Shing Cheung Frontiers in Immunology.2025;[Epub] CrossRef
Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac Li-Na Zhang, Jing-Tong Tan, Ho-Yu Ng, Yun-Shi Liao, Rui-Qi Zhang, Kwok-Hung Chan, Ivan Fan-Ngai Hung, Tommy Tsan-Yuk Lam, Ka-Shing Cheung Vaccines.2024; 12(4): 365. CrossRef
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial Ka Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui, Lok Ka Lam, Lung Yi Mak, Yuen Chi Ho, Jing Tong Tan, Esther W. Chan, Wai Kay Seto, Man Fung Yuen, Wai K. Leung Hepatology.2024; 80(4): 916. CrossRef
Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients Ka Shing Cheung, Vincent K C Yan, Xuxiao Ye, Ivan F N Hung, Esther W Chan, Wai K Leung Journal of Gastroenterology and Hepatology.2024; 39(9): 1837. CrossRef
Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant Lok Ka Lam, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Xianhua Mao, Ivan F N Hung, Wai Kay Seto, Man Fung Yuen, Ka Shing Cheung Journal of Gastroenterology and Hepatology.2024; 39(11): 2386. CrossRef
Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients Jin Cui, Lianbang Wang, Armin Ghavamian, Xuemei Li, Gongzheng Wang, Tao Wang, Min Huang, Qi Ru, Xinya Zhao BMC Gastroenterology.2024;[Epub] CrossRef
Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis” Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen Clinical and Molecular Hepatology.2023; 29(1): 176. CrossRef
Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity Ho Yu Ng, Wai K. Leung, Ka Shing Cheung Microorganisms.2023; 11(2): 452. CrossRef
COVID-19 and MAFLD/NAFLD: An updated review Ali Nowroozi, Sara Momtazmanesh, Nima Rezaei Frontiers in Medicine.2023;[Epub] CrossRef
Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients Ka Shing Cheung, Lok Ka Lam, Xianhua Mao, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Ivan F. N. Hung, Wai Kay Seto, Man Fung Yuen Vaccines.2023; 11(3): 497. CrossRef
Research Progress of Novel Coronavirus Vac-cine in Patients with Chronic Liver Disease 露 王 Advances in Clinical Medicine.2023; 13(04): 6745. CrossRef
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease Hendrik Luxenburger, Robert Thimme Gut.2023; 72(9): 1783. CrossRef
COVID-19 and Fatty Liver Disorders Maria Guarino, Valentina Cossiga, Francesco Cutolo, Maria Attanasio, Raffaele Lieto, Filomena Morisco Journal of Clinical Medicine.2023; 12(13): 4316. CrossRef
Antibiotic Use Prior to COVID-19 Vaccine Is Associated with Higher Risk of COVID-19 and Adverse Outcomes: A Propensity-Scored Matched Territory-Wide Cohort Ka Shing Cheung, Vincent K. C. Yan, Lok Ka Lam, Xuxiao Ye, Ivan F. N. Hung, Esther W. Chan, Wai K. Leung Vaccines.2023; 11(8): 1341. CrossRef
Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants Chomchanat Tubjaroen, Sittichoke Prachuapthunyachart, Nattakoon Potjalongsilp, Pimpayao Sodsai, Nattiya Hirankarn, Peera Jaru-Ampornpan, Voranush Chongsrisawat Vaccines.2022; 10(11): 1867. CrossRef
Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry Jihyun An, Young Chang, Gwang Hyeon Choi, Won Sohn, Jeong Eun Song, Hyunjae Shin, Jae Hyun Yoon, Jun Sik Yoon, Hye Young Jang, Eun Ju Cho, Ji Won Han, Suk Kyun Hong, Ju-Yeon Cho, Kyu-Won Jung, Eun Hye Park, Eunyang Kim, Bo Hyun Kim Journal of Liver Cancer.2025; 25(1): 109. CrossRef
Trends in Prevalence of Obesity and Related Cardiometabolic and Renal Complications in Korea: A Nationwide Study 2007 to 2022 Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Jangho Lee, Yong-ho Lee Journal of Obesity & Metabolic Syndrome.2025; 34(4): 414. CrossRef
The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis Log Young Kim, Jeong-Ju Yoo, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Dong Hyeon Lee, Jae Young Jang Journal of Korean Medical Science.2024;[Epub] CrossRef
Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun Gut and Liver.2024; 18(2): 305. CrossRef
Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma: Real-World Experience Dae-Ho Choi, Sang Eun Yoon, Junhun Cho, Seok Jin Kim, Won Seog Kim Acta Haematologica.2024; 147(6): 625. CrossRef
Sex and ethnic disparities in hepatitis B evaluation and treatment across the world Sahith Kudaravalli, Daniel Q. Huang, Ming-Lun Yeh, Lindsey Trinh, P.C. Tsai, Yao-Chun Hsu, Leslie Y. Kam, Vy H. Nguyen, Eiichi Ogawa, Dong Hyun Lee, Takanori Ito, Tsunamasa Watanabe, Masaru Enomoto, Carmen Monica Preda, Michael K.L. Ko, Rex Wan-Hin Hui, M Journal of Hepatology.2024; 81(1): 33. CrossRef
Association between Vitamin D Deficiency and Serologic Response to Hepatitis B Virus Vaccination among Heavy Industry Workers Si-Ho Kim, Chang-Ho Chae Vaccines.2024; 12(7): 723. CrossRef
SOD1 inhibition enhances sorafenib efficacy in HBV‐related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS‐mediated cell death Jooyoung Lee, Jiye Kim, Ryunjin Lee, Eunkyeong Lee, Hye‐In An, Yong‐Jae Kwon, Hana Jin, Chan‐Gi Pack, Inki Kim, Young‐In Yoon, Gil‐Chun Park, Eun‐Kyoung Jwa, Jae Hyun Kwon, Jung‐Man Namgoong, Gi‐Won Song, Shin Hwang, Eunyoung Tak, Sung‐Gyu Lee Journal of Cellular and Molecular Medicine.2024;[Epub] CrossRef
Evaluation of the acute hepatitis B surveillance system in the Republic of Korea following the transition to mandatory surveillance Jaehwa Chung, Jeonghee Yu, Myeongeun Cheon, Sangwoo Tak Osong Public Health and Research Perspectives.2024; 15(4): 353. CrossRef
Potential Association between Shift Work and Serologic Response to Hepatitis B Vaccination among Manufacturing Workers in Republic of Korea Si-Ho Kim, Chang-Ho Chae Vaccines.2024; 12(9): 1041. CrossRef
Detection of hepatitis B virus genotypes in a group of hepatitis B virus-infected patients in central and northern Sri Lanka T. T. Pattiyakumbura, K. G. K. Malkanthi, W. K. H. Dheerasekara, A. Manamperi, M. A. R. V. Muthugala
Access Microbiology
.2024;[Epub] CrossRef
Isolated Hepatitis B Core Antibody Positivity and Long-Term Liver-Related Mortality in Korea: A Cohort Study Won Sohn, Yoosoo Chang, Yong Kyun Cho, Yun Soo Hong, Seungho Ryu American Journal of Gastroenterology.2023; 118(1): 95. CrossRef
Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim Hepatology Communications.2023; 7(2): e0011. CrossRef
Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea Chungman Chae, Sangwoo Tak Osong Public Health and Research Perspectives.2023; 14(2): 138. CrossRef
Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han Infectious Diseases and Therapy.2023; 12(10): 2387. CrossRef
Healthy Spouses can be Considered as Living Liver Donors Okjoo Lee, Jong Man Kim, Sang Jin Kim, Jinsoo Rhu, Gyu‐Seong Choi, Jae‐Won Joh World Journal of Surgery.2022; 46(6): 1474. CrossRef
Hepatitis A virus is one of the most frequent causes of foodborne infection, which is closely associated with sanitary conditions and hygienic practices. The clinical spectrum of acute hepatitis A is wide, ranging from mild case without any noticeable symptoms to severe case with acute liver failure leading to mortality. The severity and outcome are highly correlated with age at infection. In developing countries, most people are infected in early childhood without significant symptom. Ironically, in area where sanitary condition has improved rapidly, adults who do not have immunity for viral hepatitis A (VH-A) in early childhood is accumulating. Adults without immunity are exposed to risks of symptomatic disease and large outbreaks in society. In Korea, where hygiene has improved rapidly, acute hepatitis A is a significant health burden that needs to be managed with nationwide health policy. The incidence of symptomatic VH-A has increased since 2000 and peaked in 2009. Korea has designated hepatitis A as a group 1 nationally notifiable infectious disease in 2001. Since 2001, mandatory surveillance system has been established to detect every single case of acute hepatitis A. Universal, nationwide vaccination program for newborns was introduced in 2015. In this review, we will present the current epidemiologic status of viral hepatitis A, and evaluate the effectiveness of the current nationwide strategies for the control of viral hepatitis A in Korea. Furthermore, we presented some action proposals that can help eliminate viral hepatitis A, which is a significant health burden in Korea.
Citations
Citations to this article as recorded by
Hepatitis A: A wake-up call! Anil Chandra Anand, Akash Roy Indian Journal of Gastroenterology.2025; 44(5): 581. CrossRef
The Shifting Epidemiology of Hepatitis A in the World Health Organization Western Pacific Region Nina G. Gloriani, Sheriah Laine M. de Paz-Silava, Robert D. Allison, Yoshihiro Takashima, Tigran Avagyan Vaccines.2024; 12(2): 204. CrossRef
Current perspectives of viral hepatitis Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef
Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination Omid Gholizadeh, Sama Akbarzadeh, Mohamad Ghazanfari Hashemi, Marjan Gholami, Parya Amini, Zahra Yekanipour, Raheleh Tabatabaie, Saman Yasamineh, Parastoo Hosseini, Vahdat Poortahmasebi, Lalit Batra Canadian Journal of Infectious Diseases and Medical Microbiology.2023;[Epub] CrossRef
Investigating the spatio-temporal variation of hepatitis A in Korea using a Bayesian model Jaehong Jeong, Mijeong Kim, Jungsoon Choi Frontiers in Public Health.2023;[Epub] CrossRef
Antibody Positivity Rates of Vaccine-preventable Diseases among New Healthcare Workers in a Teaching Hospital and Affecting Factors, 2019-2023 Eunjung Kim, Se Ju Lee, Jae Hyoung Im, Jin-Soo Lee, Jihyeon Baek Korean Journal of Healthcare-Associated Infection Control and Prevention.2023; 28(2): 216. CrossRef
Influence of temperature and precipitation on the incidence of hepatitis A in Seoul, Republic of Korea: a time series analysis using distributed lag linear and non-linear model Kiook Baek, Jonghyuk Choi, Jong-Tae Park, Kyeongmin Kwak International Journal of Biometeorology.2022; 66(9): 1725. CrossRef
Epidemiology of liver failure in Asia‐Pacific region Ankur Jindal, Shiv K. Sarin Liver International.2022; 42(9): 2093. CrossRef
The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea Dae Hyun Lim, Won Sohn, Jae Yoon Jeong, Hyunwoo Oh, Jae Gon Lee, Eileen L. Yoon, Tae Yeob Kim, Seungwoo Nam, Joo Hyun Sohn Medicine.2022; 101(48): e31639. CrossRef
Hepatitis A Outbreak Characteristics: A Comparison of Regions with Different Vaccination Strategies, Spain 2010–2018 Angela Domínguez, Carmen Varela, Núria Soldevila, Conchita Izquierdo, María Guerrero, Marina Peñuelas, Ana Martínez, Pere Godoy, Eva Borràs, Cristina Rius, Núria Torner, Ana María Avellón, Jesús Castilla Vaccines.2021; 9(11): 1214. CrossRef
The changing gender differences in hepatitis a incidence in South Korea Young June Choe, Hyunjin Son Vaccine.2020; 38(4): 712. CrossRef
Autoimmune Hepatic Failure Following Acute Hepatitis A is Accompanied by Inflammatory Conversion of Regulatory T Cells Galam Leem, Beom Kyung Kim, Eui-Cheol Shin, Jun Yong Park Yonsei Medical Journal.2020; 61(1): 100. CrossRef
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen Intestinal Research.2020; 18(1): 18. CrossRef
Case Report for Severe Hepatitis A Treated in a Korean Hospital Sul-Ki Kim, Cheon-Hoo Jeon, Nam-Heon Lee, Jung-Hyo Cho, Chang-Gue Son Journal of Korean Medicine.2020; 41(4): 100. CrossRef
A Model to Predict 1‐Month Risk of Transplant or Death in Hepatitis A–Related Acute Liver Failure Jin Dong Kim, Eun Ju Cho, Choonghyun Ahn, Sue K. Park, Jong Young Choi, Han Chu Lee, Do Young Kim, Moon Seok Choi, Hee Jung Wang, In Hee Kim, Jong Eun Yeon, Yeon Seok Seo, Won Young Tak, Moon Young Kim, Heon Ju Lee, Yun Soo Kim, Dae Won Jun, Joo Hyun Sohn Hepatology.2019; 70(2): 621. CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93. CrossRef
Seroprevalence of Hepatitis A Virus in Pediatric Patients with Hematologic Malignancies after Chemotherapy and Hematopoietic Cell Transplantation Ja Un Moon, A-Luem Han, Eui Soo Lee, Seong koo Kim, Seung Beom Han, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, Dae Chul Jeong, Jin Han Kang Infection & Chemotherapy.2019; 51(2): 183. CrossRef
Perspectives on Acute Hepatitis A Control in Korea Seong Hee Kang, Moon Young Kim, Soon Koo Baik Journal of Korean Medical Science.2019;[Epub] CrossRef
Causes and countermeasures for repeated outbreaks of hepatitis A among adults in Korea Moran Ki, Hyunjin Son, Bo Youl Choi Epidemiology and Health.2019; 41: e2019038. CrossRef
A Case of Graves' Disease Accompanied with Acute Hepatitis A Virus Infection Seong Eun Hong, Jin Woo Choo, Soo Kyung Lim, Seong Jin Lee, Ji Won Park, Sung Eun Kim, Jong Hyeok Kim, Choong Kee Park The Korean Journal of Gastroenterology.2018; 71(6): 354. CrossRef
Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea Jae-Cheol Kwon, Hye Young Chang, Oh Young Kwon, Ji Hoon Park, In Soo Oh, Hyung Joon Kim, Jun Hyung Lee, Ha-Jung Roh, Hyun Woong Lee Yonsei Medical Journal.2018; 59(9): 1072. CrossRef
Understanding Hepatitis B Knowledge, Attitudes, and Stigma in the Korean Community in Australia Youngnam Baek, Robyn Horwitz, Loren Brener, Sylvester Okeke, Tim Broady, Carla Treloar, Elena Cama Journal of Racial and Ethnic Health Disparities.2025;[Epub] CrossRef
Vitamin K: Calcium Metabolism Modulator for Menopausal Women Tae-Hee Kim, Hayeon Kim, Hae Hyeog Lee, Jae Hong Sang Journal of Menopausal Medicine.2024; 30(3): 152. CrossRef
A Study on the Trend of Changes in the Positive Rate of Hepatitis B Surface Antigens and Antibodies over the Last 9 Years in One Health Care Center Kang-Sil Lee, Sang-Ha Kim, Young-Bin Yu, Young-Kwon Kim Biomedical Science Letters.2023; 29(4): 314. CrossRef
Long-term outcomes of primary total knee arthroplasty in patients with hepatitis B virus infection Ji-Hoon Baek, Su C. Lee, Suengryol Ryu, Jin-Woo Kim, Chang H. Nam Bone & Joint Open.2022; 3(6): 470. CrossRef
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee Clinical and Molecular Hepatology.2020; 26(4): 411. CrossRef
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Ki American Journal of Gastroenterology.2020; 115(8): 1217. CrossRef
Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level Yeojun Yun, Yoosoo Chang, Han-Na Kim, Seungho Ryu, Min-Jung Kwon, Yong Kyun Cho, Hyung-Lae Kim, Hae Suk Cheong, Eun-Jeong Joo Journal of Clinical Medicine.2019; 8(2): 173. CrossRef
Updated Treatment of Chronic Hepatitis B Eileen L. Yoon, Hyung Joon Yim The Korean Journal of Medicine.2019; 94(3): 252. CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93. CrossRef
Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea Jae-Cheol Kwon, Hye Young Chang, Oh Young Kwon, Ji Hoon Park, In Soo Oh, Hyung Joon Kim, Jun Hyung Lee, Ha-Jung Roh, Hyun Woong Lee Yonsei Medical Journal.2018; 59(9): 1072. CrossRef
Negative Association of Hepatitis B Virus With Hearing Impairment SKM Azizul Islam, Jin Wook Chung, Young-Sil Lee, HoChan Cho, Seong-Su Moon American Journal of Audiology.2018; 27(3): 324. CrossRef
Large-scale surveillance study of the safety and effectiveness of entecavir in Korean patients with chronic hepatitis B Chang Wook Kim, Chang Seop Kim, Hee Yeon Kim, Chang Don Lee, Kyungha Yu, Cyril Llamoso, Heon Ju Lee The Korean Journal of Internal Medicine.2018; 33(1): 91. CrossRef
An expert consensus for the management of chronic hepatitis B in Asian Americans M. J. Tong, C. Q. Pan, S.‐H. B. Han, D. S.‐K. Lu, S. Raman, K.‐Q. Hu, J. K. Lim, H. W. Hann, A. D. Min Alimentary Pharmacology & Therapeutics.2018; 47(8): 1181. CrossRef
Therapeutic Efficacy of Lamivudine in Children and Adolescents with Chronic Hepatitis B Yujung Choi, Kil Seoung Bae, Ki Hwan Kim, Dae Kyun Koh, Jong-Hyun Kim Pediatric Infection & Vaccine.2018; 25(2): 72. CrossRef
How can we improve the performance of Model for End‐Stage Liver Disease sodium score in patients with hepatitis B virus‐related decompensated liver cirrhosis commencing antiviral treatment? Tae Hyung Kim, Dae Hoe Ku, Soon Ho Um, Han Ah Lee, Seung Woon Park, Jung Mi Chang, Sun Young Yim, Sang Jun Suh, Young Kul Jung, Yeon Seok Seo, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Hyonggin Ahn Journal of Gastroenterology and Hepatology.2018; 33(9): 1641. CrossRef
The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B Jae Min Lee, Yeon Seok Seo, Tae Hyung Kim, Jem Ma Ahn, Sun Young Yim, Seung Up Kim, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Hong Sik Lee, Kwan Soo Byun, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu Journal of Gastroenterology and Hepatology.2017; 32(1): 208. CrossRef
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh Clinical and Molecular Hepatology.2017; 23(4): 331. CrossRef
A Case Report of the Efficacy of Saenggan-tang-gagam in the Treatment of a Patient with Chronic Hepatitis B Who Showed Conversion of the Immune-Tolerant Phase to Immune-Clearance Phase during Hospitalization for Intracerebral Hemorrhage Jung-han Bae, Ha-yeon Kim, Seong-hee Joo, Eun-gyeong Jang, Jang-hoon Lee, Young-chul Kim The Journal of Internal Korean Medicine.2017; 38(2): 164. CrossRef
Association of Hepatitis B Virus Infection and Psoriasis Hyun-Yi Suh, Yong-Bum Yoon, Ji-Young Ahn, Mi-Youn Park, Jai-Il Youn Annals of Dermatology.2017; 29(6): 822. CrossRef
The Economic Burden of Hepatitis A, B, and C in South Korea Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef
KASL clinical practice guidelines: management of chronic hepatitis B
Clinical and Molecular Hepatology.2016; 22(1): 18. CrossRef
Association of HLA-DP variants with the responsiveness to Hepatitis B virus vaccination in Korean Infants Eun Youn Roh, Jong Hyun Yoon, Ji Won In, Nuri Lee, Sue Shin, Eun Young Song Vaccine.2016; 34(23): 2602. CrossRef
A 96‐week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy Sang Hoon Ahn, Jeong Heo, Jun Yong Park, Hyun Young Woo, Heon Ju Lee, Won Young Tak, Soon Ho Um, Ki Tae Yoon, Soo Young Park, Chang Wook Kim, Hyung Hoi Kim, Kwang‐Hyub Han, Mong Cho Journal of Gastroenterology and Hepatology.2016; 31(4): 865. CrossRef
Age-Period-Cohort Analysis of Liver Cancer Mortality in Korea Jihwan Park, Yon Ho Jee Asian Pacific Journal of Cancer Prevention.2016; 16(18): 8589. CrossRef
Prevalence of Hepatitis B Virus and HIV Co-infection in Korea Hyun-Ho Lee, Hae-Guen Hong, Jong-Seong Son, Sun-Mok Kwon, Bu-Geon Lim, Kang-Bum Lee, Gu-Hwan Kim Journal of Bacteriology and Virology.2016; 46(4): 283. CrossRef
Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B Jeong-Ju Yoo, Jeong-Hoon Lee, Jung-Hwan Yoon, Minjong Lee, Dong Hyeon Lee, Yuri Cho, Eun Sun Jang, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Hyo-Suk Lee Gastroenterology Research and Practice.2015; 2015: 1. CrossRef
Efficacy of telbivudine compared with entecavir in hepatitis B virus‐related cirrhosis: 2 year follow‐up data Hae Rim Kim, Hyung Joon Yim, Seonghee Kang, Sang Jun Suh, Seung Young Kim, Jong Jin Hyun, Ja Seol Koo, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Sang Woo Lee, Kwan Soo Byun, Soon Ho Um Liver International.2015; 35(3): 860. CrossRef
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels Junggyu Lee, Dong Hyun Sinn, Jung Hee Kim, Geum-Youn Gwak, Hye Seung Kim, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik Journal of Korean Medical Science.2015; 30(11): 1618. CrossRef
Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy Markus Unnewehr, August Stich Journal of Korean Medical Science.2015; 30(11): 1584. CrossRef
Analysis of HBV genotype, drug resistant mutations, and pre‐core/basal core promoter mutations in Korean patients with acute hepatitis B Jong Ho Lee, Sun Pyo Hong, Eun Sun Jang, Sang Jong Park, Seong Gyu Hwang, Sook‐Kyoung Kang, Sook‐Hyang Jeong Journal of Medical Virology.2015; 87(6): 993. CrossRef
Clinical Characteristics of Defectors from North Korea Visiting a Single Tertiary Hospital in South Korea Sun Young Ann, Sung Hyeok Ryou, Suk Bae Kim Korean Journal of Medicine.2015; 89(1): 54. CrossRef
Blood Lead Levels and Cause-Specific Mortality of Inorganic Lead-Exposed Workers in South Korea Min-Gi Kim, Jae-Hong Ryoo, Se-Jin Chang, Chun-Bae Kim, Jong-Ku Park, Sang-Baek Koh, Yeon-Soon Ahn, Max Costa PLOS ONE.2015; 10(10): e0140360. CrossRef
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas Sejong Chun, Su Yeon Rhie, Chang-Seok Ki, Jee Eun Kim, Hyung-Doo Park Annals of Hepatology.2015; 14(6): 881. CrossRef
Iron deficient erythropoiesis might play key role in development of anemia in cancer patients Silvia Park, Chul Won Jung, Kihyun Kim, Seok Jin Kim, Won Seog Kim, Jun Ho Jang Oncotarget.2015; 6(40): 42803. CrossRef
Prevalence of and Factors Influencing Impaired Glucose Tolerance Among Hepatitis B Carriers Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun Medicine.2014; 93(20): e91. CrossRef
The association between underweight and the development of albuminuria is different between sexes in relatively healthy Korean subjects C. M. Jang, Y. Y. Hyun, K. B. Lee, H. Kim Nephrology Dialysis Transplantation.2014; 29(11): 2106. CrossRef
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon Clinical and Molecular Hepatology.2014; 20(3): 274. CrossRef
Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants Jong Hyun Yoon, Sue Shin, Ji won In, Ju Young Chang, Eun Young Song, Eun Youn Roh Vaccine.2014; 32(43): 5638. CrossRef
Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea Sang Soo Lee, Young-Sang Byoun, Sook-Hyang Jeong, Byung Hyun Woo, Eun Sun Jang, Jin-Wook Kim, Hyun Young Kim Digestive Diseases and Sciences.2014; 59(12): 2967. CrossRef
Correlation Between Risk of Hepatitis B Virus Recurrence and Tissue Expression of Covalently Closed Circular DNA in Living Donor Liver Transplant Recipients Treated With High-dose Hepatitis B Immunoglobulin G.-W. Song, C.-S. Ahn, S.-G. Lee, S. Hwang, K.-H. Kim, D.-B. Moon, T.-Y. Ha, D.-H. Jung, G.-C. Park, S.-H. Kang, B.-H. Jung, N. Kim Transplantation Proceedings.2014; 46(10): 3548. CrossRef
Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort Dong Hyun Sinn, Geum-Youn Gwak, Juhee Cho, Seung Woon Paik, Byung Chul Yoo, Pierre Roques PLoS ONE.2014; 9(11): e112184. CrossRef
Determinants of suboptimal hepatitis B vaccine uptake among men in the Republic of Korea: where should our efforts be focused: results from cross-sectional study Boyoung Park, Kui Son Choi, Hoo-Yeon Lee, Min-Son Kwak, Jae Kwan Jun, Eun-Cheol Park BMC Infectious Diseases.2013;[Epub] CrossRef
Clinical Characteristics and Treatment of Patients with IgA Nephropathy and Hepatitis B Surface Antigen In O Sun, Yu Ah Hong, Hoon Suk Park, Sun Ryoung Choi, Byung Ha Chung, Cheol Whee Park, Chul Woo Yang, Yong Soo Kim, Bum Soon Choi Renal Failure.2013; 35(4): 446. CrossRef
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon Clinical and Molecular Hepatology.2013; 19(4): 409. CrossRef
Recent trends in hepatitis B virus infection in the general Korean population Hyuck Kim, A Ri Shin, Hoe Hoon Chung, Min Kyoung Kim, Ji Sung Lee, Jae-Jun Shim, Byung-Ho Kim The Korean Journal of Internal Medicine.2013; 28(4): 413. CrossRef
The Roles of Immune Regulatory Factors FoxP3, PD-1, and CTLA-4 in Chronic Viral Infection Hyosun Cho The Korean Journal of Microbiology.2013; 49(3): 221. CrossRef
Viral Hepatitis and Liver Cancer in Korea: an Epidemiological Perspective Yohwan Yeo, Jin Gwack, Seokin Kang, Boyeon Koo, Sun Jae Jung, Prakash Dhamala, Kwang-Pil Ko, Young-Khi Lim, Keun-Young Yoo Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6227. CrossRef
Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti‐HBs Byung Seok Lee, Yong Kyun Cho, Sook‐Hyang Jeong, Joon Hyeok Lee, Don Lee, Neung Hwa Park, Moran Ki Journal of Medical Virology.2013; 85(8): 1327. CrossRef
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee Clinical and Molecular Hepatology.2013; 19(3): 273. CrossRef
Work-related infectious diseases among Korean workers compensated under the Industrial Accident Compensation Insurance Law, 2006–2011 Jun-Pyo Myong, Yeon-Soon Ahn, Hyoung-Ryoul Kim, Youn Jeong Kim, Chung Yill Park, Jung-Wan Koo International Journal of Occupational and Environmental Health.2013; 19(4): 344. CrossRef
Prevention of Viral Hepatitis and Vaccination Yoo-Kyung Cho, Byung-Cheol Song Korean Journal of Medicine.2012; 82(2): 123. CrossRef
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Clinical and Molecular Hepatology.2012; 18(2): 109. CrossRef
Prevalence of rheumatoid factor and parameters associated with rheumatoid factor positivity in Korean health screening subjects and subjects with hepatitis B surface antigen Choong-Nam Shim, Ji-Won Hwang, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha, Joong Kyong Ahn Modern Rheumatology.2012; 22(6): 885. CrossRef
Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study Sang Hoon Park, Choong Kee Park, Jin Woo Lee, Young Seok Kim, Sook-Hyang Jeong, Yun Soo im, Ju Hyun Kim, Seong Gyu Hwang, Kyu Sung Rim, Hyung Joon Yim, Jae Youn Cheong, Sung Won Cho, June Sung Lee, Young Min Park, Jeong Won Jang Chun Kyon Lee, Joo Hyun Sh Gut and Liver.2012; 6(1): 98. CrossRef
Prognosis of hepatitis B‐related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents Chang Ha Kim, Soon Ho Um, Yeon Seok Seo, Jin Yong Jung, Jin Dong Kim, Hyung Joon Yim, Bora Keum, Yong Sik Kim, Yoon Tae Jeen, Hong Sik Lee, Hoon Jai Chun, Chang Duck Kim, Ho Sang Ryu Journal of Gastroenterology and Hepatology.2012; 27(10): 1589. CrossRef
The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study Moon Seok Choi, Dong Hyun Sinn, Su-A Kim, Yil Seob Lee, Won Choi, Seung Woon Paik Gut and Liver.2012; 6(2): 241. CrossRef
Socioeconomic inequalities in completion of hepatitis B vaccine series among Korean women: Results from a nationwide interview survey Boyoung Park, Kui Son Choi, Hoo-Yeon Lee, Jae Kwan Jun, Eun-Cheol Park Vaccine.2012; 30(40): 5844. CrossRef
Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B Jeong Han Kim, So Young Kwon, Young Sok Lee, Joon Hyoek Lee, Yil–Seob Lee, Chang Hong Lee Clinical Gastroenterology and Hepatology.2012; 10(3): 291. CrossRef
Serum Selenium Levels in Korean Hepatoma Patients In-Wook Kim, Su-Mi Bae, Yong-Wan Kim, Hai-Bo Liu, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Pankaj Kumar Chaturvedi, Gantumur Battogtokh, Woong Shick Ahn Biological Trace Element Research.2012; 148(1): 25. CrossRef
Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea Younghee Jung, Myung Jin Lee, Hye-Yun Sin, Nak-Hyun Kim, Jeong-Hwan Hwang, Jinyong Park, Pyoeng Gyun Choe, Wan Beom Park, Eu Suk Kim, Sang-Won Park, Kyoung Un Park, Hong Bin Kim, Nam-Joong Kim, Eui-Chong Kim, Kyoung-Ho Song, Myoung-don Oh BMC Infectious Diseases.2012;[Epub] CrossRef
Hepatitis B: Epidemiology and prevention in developing countries Elisabetta Franco World Journal of Hepatology.2012; 4(3): 74. CrossRef
Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients Min-Sun Kwak, Eun-Ju Cho, Eun-Sun Jang, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee Digestion.2011; 84(s1): 23. CrossRef
Comparison of cancer incidence between production and office workers at a shipyard in Korea: A retrospective cohort study from 1992 to 2005 Kyoung‐Sook Jeong, Yangho Kim, Moon‐Chan Kim, Cheol‐In Yoo American Journal of Industrial Medicine.2011; 54(9): 719. CrossRef
The Management of Chronic Hepatitis B in Asian Americans Myron J. Tong, Calvin Q. Pan, Hie-Won Hann, Kris V. Kowdley, Steven-Huy B. Han, Albert D. Min, Truong-Sinh Leduc Digestive Diseases and Sciences.2011; 56(11): 3143. CrossRef
Trend in Viral Infectious Diseases in Children Sung Hee Oh Infection and Chemotherapy.2011; 43(6): 435. CrossRef
Infectious diseases in children and adolescents in the Republic of Korea; Past & recent status Jong-Hyun Kim Korean Journal of Pediatrics.2011; 54(12): 489. CrossRef
Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers Jaejun Shim, Kyung Yup Kim, Byung-Ho Kim, Heekyung Chun, Mi Suk Lee, Young Hwangbo, Jae Young Jang, Seok Ho Dong, Hyo Jong Kim, Young Woon Chang, Rin Chang Vaccine.2011; 29(8): 1721. CrossRef
Use of Oral Hypoglycemic Agents in Type 2 Diabetic Patients with Hepatic Dysfunction Ki Young Lee Journal of Korean Diabetes.2011; 12(4): 190. CrossRef
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy J Yun, K H Kim, E S Kang, G-Y Gwak, M S Choi, J E Lee, S J Nam, J-H Yang, Y H Park, J S Ahn, Y-H Im British Journal of Cancer.2011; 104(4): 559. CrossRef
Liver transplantation in South Korea Soo Ryang Kim Kanzo.2011; 52(2): 150. CrossRef
Shifting in Seroprevalence of HBsAg and Anti-HCV during Recent 10 Years in Adults Resident in Daegu and Gyeongbuk Province Kyung In Lee, Kyung Sik Park, Hye Jin Seo, Tae Yul Kim, Eun Soo Kim, Byoung Kuk Jang, Woo Jin Chung, Kwang Bum Cho, Jae Seok Hwang The Korean Journal of Gastroenterology.2011; 58(2): 82. CrossRef
Clinical Features of Retinopathy in Chronic Hepatitis B Patients With Treated With Peginterferon Yong Dae Kwon, Ji Won Lim Journal of the Korean Ophthalmological Society.2011; 52(1): 41. CrossRef
Clinical features of acute viral hepatitis B in Korea: a multi-center study Hye Jin Choi, Soon Young Ko, Won Hyeok Choe, Yeon Seok Seo, Ji Hoon Kim, Kwan Soo Byun, Young Seok Kim, Seung Up Kim, Soon Koo Baik, Jae Youn Cheong, Tae Yeob Kim, Oh Sang Kwon, Jeong Han Kim, Chang Hong Lee, So Young Kwon The Korean Journal of Hepatology.2011; 17(4): 307. CrossRef
New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B Yoo-Kyung Cho, Byung-Cheol Song The Korean Journal of Gastroenterology.2011; 57(3): 144. CrossRef
Quantitative Measurement of Serum Hepatitis B Surface Antigen Using an Immunoradiometric Assay in Chronic Hepatitis B Hyun-Woo Kwon, Ho-Young Lee, Seog Gyun Kim, Won Kim, Yong Jin Jung, Keon Wook Kang, June-Key Chung, Myung Chul Lee, Dong Soo Lee Nuclear Medicine and Molecular Imaging.2011; 45(1): 15. CrossRef
A Survey for Changed Control Policies of Hepatitis B in Republic of Korea Ji Yoon Han, Tae Woong Jung, Dae Kyun Koh, Jong Hyun Kim Korean Journal of Pediatric Infectious Diseases.2011; 18(2): 124. CrossRef
Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea Sang Ho Lee, Hyoung Su Kim, Kwon Oh Park, Jong Won Park, Seung Yeon Chun, Seung Jin Lim, Hyun Jung Cho, Sung Jun Kim, Hye Won Park, Han Kook Moon, Woon Geon Shin, Kyung Ho Kim, Myoung Kuk Jang, Jin Heon Lee, Hak Yang Kim The Korean Journal of Hepatology.2010; 16(4): 362. CrossRef
First
Prev
